Article: KOREA FOOD & DRUG AGENCY APPLIES PRESCRIPTION LIMIT TO PREPULSID.

SEOUL, July 26 Asia Pulse - The drug safety authority ordered limited prescription for Janssen Korea's drug Prepulsid (cisapride).

Prepulsid is the most widely used drug in Korea to treat gastroesophage reflux disease (GERD).

Korea Food and Drug Agency (KFDA) said Tuesday that increased reports of serious cardiovascular side effects caused by taking cisapride from local and international users prompted the authority to take it off the list of over-the-counter drugs that can be dispensed by pharmacists without a prescription.

KFDA also ordered Janssen Korea to revise the labelling by August 13 to warn users to have ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!